165 related articles for article (PubMed ID: 15317402)
1. Evidence for extended prophylaxis in the setting of orthopedic surgery.
Dobesh PP
Pharmacotherapy; 2004 Jul; 24(7 Pt 2):73S-81S. PubMed ID: 15317402
[TBL] [Abstract][Full Text] [Related]
2. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
Tran AH; Lee G
Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
[TBL] [Abstract][Full Text] [Related]
3. Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery.
Reynolds NA; Perry CM; Scott LJ
Drugs; 2004; 64(14):1575-96. PubMed ID: 15233593
[TBL] [Abstract][Full Text] [Related]
4. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Turpie AG; Bauer KA; Eriksson BI; Lassen MR
Arch Intern Med; 2002 Sep; 162(16):1833-40. PubMed ID: 12196081
[TBL] [Abstract][Full Text] [Related]
5. The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.
Turpie AG
Int J Clin Pract; 2004 May; 58(5):483-93. PubMed ID: 15206506
[TBL] [Abstract][Full Text] [Related]
6. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
7. Emerging options for thromboprophylaxis after orthopedic surgery: a review of clinical data.
Lobo BL
Pharmacotherapy; 2004 Jul; 24(7 Pt 2):66S-72S. PubMed ID: 15317401
[TBL] [Abstract][Full Text] [Related]
8. Prevention of venous thromboembolism in the orthopedic surgery patient.
Deitelzweig SB; McKean SC; Amin AN; Brotman DJ; Jaffer AK; Spyropoulos AC
Cleve Clin J Med; 2008 Apr; 75 Suppl 3():S27-36. PubMed ID: 18494224
[TBL] [Abstract][Full Text] [Related]
9. Duration of venous thromboembolism prophylaxis after surgery.
Kearon C
Chest; 2003 Dec; 124(6 Suppl):386S-392S. PubMed ID: 14668422
[TBL] [Abstract][Full Text] [Related]
10. Fondaparinux: a new synthetic and selective inhibitor of Factor Xa.
Bauer KA
Best Pract Res Clin Haematol; 2004 Mar; 17(1):89-104. PubMed ID: 15171960
[TBL] [Abstract][Full Text] [Related]
11. Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery.
Bergqvist D
Vasc Health Risk Manag; 2006; 2(4):365-70. PubMed ID: 17323590
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomics of thrombosis management.
Hawkins D
Pharmacotherapy; 2004 Jul; 24(7 Pt 2):95S-99S. PubMed ID: 15317405
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patients.
Dranitsaris G; Kahn SR; Stumpo C; Paton TW; Martineau J; Smith R; Ginsberg JS;
Am J Cardiovasc Drugs; 2004; 4(5):325-33. PubMed ID: 15449974
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery.
Sullivan SD; Kwong L; Nutescu E
Value Health; 2006; 9(2):68-76. PubMed ID: 16626410
[TBL] [Abstract][Full Text] [Related]
15. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.
Raskob GE; Hirsh J
Chest; 2003 Dec; 124(6 Suppl):379S-385S. PubMed ID: 14668421
[TBL] [Abstract][Full Text] [Related]
16. Fondaparinux sodium compared with enoxaparin sodium: a cost-effectiveness analysis.
Bjorvatn A; Kristiansen F
Am J Cardiovasc Drugs; 2005; 5(2):121-30. PubMed ID: 15725043
[TBL] [Abstract][Full Text] [Related]
17. Fondaparinux, the first selective factor Xa inhibitor.
Turpie AG; Eriksson BI; Lassen MR; Bauer KA
Curr Opin Hematol; 2003 Sep; 10(5):327-32. PubMed ID: 12913785
[TBL] [Abstract][Full Text] [Related]
18. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.
Eriksson BI; Lassen MR;
Arch Intern Med; 2003 Jun; 163(11):1337-42. PubMed ID: 12796070
[TBL] [Abstract][Full Text] [Related]
19. Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis.
Bauer KA
Am J Orthop (Belle Mead NJ); 2002 Nov; 31(11 Suppl):4-10. PubMed ID: 12463577
[TBL] [Abstract][Full Text] [Related]
20. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
